AI assistant
Fagron N.V. — M&A Activity 2013
Jul 5, 2013
3949_iss_2013-07-04_4967b375-4514-4cfc-aeff-9bb75f70c569.pdf
M&A Activity
Open in viewerOpens in your device viewer
ARSEUS DIVESTS BELGIUM BASED DORGE MEDIC
Waregem (Belgium) / Rotterdam (the Netherlands)1 , 4 July 2013 – Arseus announced today that it has completed the sale of Dorge Medic to Bastide Le Confort Médical, a company specialized in services and sales of medical tools, based in France and listed at NYSE Euronext Paris.
Established in 1991 in Temploux, Dorge Medic (part of Arseus Healthcare Solutions) provides products and value added services for mobility aids, and incontinence and stoma care in Wallonia, Belgium. In 2012, Dorge Medic generated a turnover of approximately € 3.3 million.
Under the ownership of Bastide Le Confort Médical, Christine Collin will continue as General Manager of Dorge Medic. Dorge Medic will maintain their activities in Belgium with the same dedicated team.
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.
For more information:
Constantijn van Rietschoten Director of Corporate Communications +31 88 33 11 222 (Office) +31 6 53 69 15 85 (Mobile) [email protected]
Arseus profile
Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in 30 countries worldwide. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical ICT-solutions. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.
1 This press release was sent out by Arseus NV and Arseus BV.